CA9 and renal cell carcinoma: Like the CCPRCT, ELOC-mutated RCC is CK7/CAIX/CK34βE12-positive, and the distinction between these two entities relies on a lack of prominent subnuclear vacuolization and the presence of CD10 staining in the latter [17].